Connect with us

COVID-19 WATCH

Brazil stands by hydroxychloroquine despite WHO

Agence France-Presse

Published

on

Brazilia (AFP) — Brazil’s health ministry said Monday it would not change its recommendation to treat coronavirus with hydroxychloroquine, despite the World Health Organization (WHO)deciding to suspend trials of the drug over safety concerns.

Like his US counterpart Donald Trump, Brazilian President Jair Bolsonaro has touted the supposed benefits of hydroxychloroquine and a related drug, chloroquine, against the new coronavirus.

Studies, however, have questioned their safety and efficacy against the disease, including one published Friday in respected medical journal The Lancet that found the drugs actually increased the risk of death.

That led the WHO to suspend a worldwide clinical trial of hydroxychloroquine as a COVID-19 treatment Monday.

“We’re remaining calm and there will be no change” to the Brazilian guideline issued last week, health ministry official Mayra Pinheiro told a news conference.

The guideline recommended doctors in the public health system prescribe either chloroquine or hydroxychloroquine from the onset of COVID-19 symptoms.

Advertisement
Advertisement
Advertisement